We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
-2.36%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
AUM
$367M
AUM Growth
-$53.1M
Cap. Flow
-$35.8M
Cap. Flow %
-9.76%
Top 10 Hldgs %
44.24%
Holding
122
New
7
Increased
6
Reduced
60
Closed
13

Top Buys

Rank Stock Value
1
CLX icon
Clorox
CLX
+$5.21M
2
WAB icon
Wabtec
WAB
+$516K
3
QCOM icon
Qualcomm
QCOM
+$405K
4
SPCE icon
Virgin Galactic
SPCE
+$392K
5
ASAN icon
Asana
ASAN
+$384K

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$3.88M
2
KHC icon
Kraft Heinz
KHC
+$3.81M
3
T icon
AT&T
T
+$3.41M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$2.91M
5
OSUR icon
OraSure Technologies
OSUR
+$2.25M

Sector Composition

Rank Sector Weight
1 Healthcare 22.64%
2 Consumer Staples 15.67%
3 Materials 11.16%
4 Communication Services 9.71%
5 Technology 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$131B
$36.4M 9.93%
221,815
-12,840
-5% -$2.15M
ALB icon
2
Albemarle
ALB
$13.9B
$18M 4.91%
82,158
-5,734
-7% -$1.22M
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
$16.7M 4.54%
354,339
-13,860
-4% -$668K
NTR icon
4
Nutrien
NTR
$33.2B
$15M 4.08%
228,845
-21,540
-9% -$1.32M
FDX icon
5
FedEx
FDX
$72.7B
$14.4M 3.92%
65,389
-3,970
-6% -$1.08M
BG icon
6
Bunge Global
BG
$20.4B
$13.5M 3.67%
165,446
-9,070
-5% -$700K
GILD icon
7
Gilead Sciences
GILD
$162B
$13M 3.55%
186,520
-6,920
-4% -$486K
KHC icon
8
Kraft Heinz
KHC
$30.7B
$12.9M 3.51%
350,200
-101,250
-22% -$3.81M
INTC icon
9
Intel
INTC
$455B
$11.6M 3.15%
216,810
-71,514
-25% -$3.88M
PFE icon
10
Pfizer
PFE
$143B
$11M 2.99%
254,845
-22,560
-8% -$999K
SYY icon
11
Sysco
SYY
$40.8B
$10.8M 2.95%
137,226
-6,978
-5% -$532K
CARS icon
12
Cars.com
CARS
$662M
$9.9M 2.7%
782,720
-57,350
-7% -$726K
T icon
13
AT&T
T
$159B
$9.84M 2.68%
482,463
-162,309
-25% -$3.41M
IONS icon
14
Ionis Pharmaceuticals
IONS
$8.6B
$9.77M 2.66%
291,254
-77,155
-21% -$2.91M
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.36T
$9.7M 2.64%
72,580
-2,980
-4% -$405K
MRK icon
16
Merck
MRK
$322B
$9.1M 2.48%
120,091
-13,050
-10% -$993K
KO icon
17
Coca-Cola
KO
$377B
$8.84M 2.41%
167,056
-11,570
-6% -$645K
WFC icon
18
Wells Fargo
WFC
$261B
$8.3M 2.26%
178,857
-6,280
-3% -$291K
PXD
19
DELISTED
Pioneer Natural Resource Co.
PXD
$7.42M 2.02%
44,438
-5,746
-11% -$869K
ALGN icon
20
Align Technology
ALGN
$12.1B
$7.05M 1.92%
10,599
-1,010
-9% -$686K
CPB icon
21
Campbell Soup
CPB
$6.55B
$6.09M 1.66%
145,640
-8,330
-5% -$362K
SLB icon
22
SLB Ltd
SLB
$73.6B
$5.33M 1.45%
178,973
+11,539
+7% +$331K
GH icon
23
Guardant Health
GH
$21.5B
$5.23M 1.43%
41,842
+1,322
+3% +$157K
ILMN icon
24
Illumina
ILMN
$31B
$5.21M 1.42%
13,203
-1,307
-9% -$601K
TRGP icon
25
Targa Resources
TRGP
$58B
$5.18M 1.41%
105,297
-14,530
-12% -$640K

Similar funds

Sicart Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Sicart Associates held 122 positions worth $367M, down 13% from $420M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sicart Associates withdrew a net $35.8M in Q3 2021, closing 13 positions and reducing 60 holdings. Its most notable exit was OraSure Technologies, an estimated $2.25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Consumer Staples and Materials.

Against the trend, Sicart Associates opened a new position in Clorox worth $5.01M.

  • Sicart Associates's largest Q3 2021 buy was Clorox: 30,282 shares worth $5.01M.
  • Sicart Associates added most to SLB Ltd in Q3 2021, an estimated $331K increase.
  • Sicart Associates's biggest Q3 2021 reduction was Intel, cutting an estimated $3.88M.
  • Sicart Associates fully exited OraSure Technologies in Q3 2021, selling an estimated $2.25M.
  • Sicart Associates's ten largest holdings make up 44% of its $367M portfolio in Q3 2021.
  • Sicart Associates opened 7 new positions and closed 13 in Q3 2021.
  • Sicart Associates's portfolio value fell 13% quarter-over-quarter to $367M.

Based on Sicart Associates's 13F filing for Q3 2021, filed 22 Oct 2021.